Nature Communications (Aug 2021)

Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system

  • Alexander Bolaender,
  • Danuta Zatorska,
  • Huazhong He,
  • Suhasini Joshi,
  • Sahil Sharma,
  • Chander S. Digwal,
  • Hardik J. Patel,
  • Weilin Sun,
  • Brandon S. Imber,
  • Stefan O. Ochiana,
  • Maulik R. Patel,
  • Liza Shrestha,
  • Smit. K. Shah,
  • Shuo Wang,
  • Rashad Karimov,
  • Hui Tao,
  • Pallav D. Patel,
  • Ananda Rodilla Martin,
  • Pengrong Yan,
  • Palak Panchal,
  • Justina Almodovar,
  • Adriana Corben,
  • Andreas Rimner,
  • Stephen D. Ginsberg,
  • Serge Lyashchenko,
  • Eva Burnazi,
  • Anson Ku,
  • Teja Kalidindi,
  • Sang Gyu Lee,
  • Milan Grkovski,
  • Bradley J. Beattie,
  • Pat Zanzonico,
  • Jason S. Lewis,
  • Steve Larson,
  • Anna Rodina,
  • Nagavarakishore Pillarsetty,
  • Viviane Tabar,
  • Mark P. Dunphy,
  • Tony Taldone,
  • Fumiko Shimizu,
  • Gabriela Chiosis

DOI
https://doi.org/10.1038/s41467-021-24821-2
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 19

Abstract

Read online

Here, the authors show structural, biochemical, and functional insights into the discovery of epichaperome‐ directed chemical probes for use in central nervous system diseases. Probes emerging from this work have translated to human clinical studies in Alzheimer’s disease and cancer.